GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹752 Cr | ₹2,186 Cr | ₹-1,560 Cr | ₹1,587 Cr | ₹-177 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLAND PHARMA ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹752 Cr |
| Mar2025 | ₹2,186 Cr |
| Mar2024 | ₹-1,560 Cr |
| Mar2023 | ₹1,587 Cr |
| Mar2022 | ₹-177 Cr |
How is Net Cash Inflow / Outflow of GLAND PHARMA Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹752 Cr | -65.59 | |
| Mar2025 | ₹2,186 Cr | Positive | |
| Mar2024 | ₹-1,560 Cr | Negative | |
| Mar2023 | ₹1,587 Cr | Positive | |
| Mar2022 | ₹-177 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹54,302.3 Cr | -1.3% | 12.5% | 76.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -1.3% |
12.5% |
76.4% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses